IFNG and neoplasm: Tumor cells and T cells compete for nutrient such as glucose in tumor microenvironment, and predominant glucose consumption by tumors metabolically restricts T cell functions (e.g., reduction of mTOR activity/glycolytic capacity/IFN-γ production).